Sunmax Biotechnology Co., Ltd. (TPEX: 4728)

Sunmax Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	603.5	854.69	589.3	602.55	778.58	583.49
Short-Term Investments	50	107.1	227.37	76.79	131.01	122.94
Trading Asset Securities	-	-	-	-	-	21.48
Cash & Short-Term Investments	653.5	961.79	816.67	679.34	909.59	727.91
Cash Growth	-18.86%	17.77%	20.22%	-25.31%	24.96%	38.31%
Accounts Receivable	2.77	2.55	1.94	3.72	7.63	21.17
Other Receivables	10.8	6.84	1.37	4.71	2.88	17.22
Receivables	13.57	9.39	3.3	8.43	10.51	38.39
Inventory	141.68	93.67	73.79	54.74	25.33	41.2
Other Current Assets	42.84	14.08	11.81	45.06	20.09	18.22
Total Current Assets	851.58	1,079	905.58	787.57	965.53	825.71
Property, Plant & Equipment	959.28	904.32	604.39	485.56	277.18	138.65
Long-Term Investments	-	-	10.3	17.18	7.48	32.88
Other Intangible Assets	3.65	5.06	3.84	3.84	5.18	8.74
Long-Term Deferred Tax Assets	33.59	53.39	20.76	17.32	11.82	11.62
Other Long-Term Assets	19.56	117.33	248.41	172.55	96.93	95.05
Total Assets	1,868	2,159	1,793	1,484	1,364	1,113
Accounts Payable	15.06	11.98	21.77	14.95	7.18	9.88
Current Portion of Leases	23.88	24.24	13.27	32.28	24.69	7.16
Current Income Taxes Payable	46.81	89.03	82.94	70.84	29.13	32.68
Current Unearned Revenue	56.63	202.57	60.09	122.95	111.56	158.34
Other Current Liabilities	108.37	129.62	147.93	92.93	121.95	67.56
Total Current Liabilities	250.75	457.43	326	333.95	294.51	275.62
Long-Term Leases	130.89	144.78	49.82	66.9	105.27	109.82
Long-Term Deferred Tax Liabilities	92.26	105.19	57.16	22.16	39.4	12.87
Other Long-Term Liabilities	26.62	25.59	35.02	37.43	36.09	34.96
Total Liabilities	500.52	732.99	468	460.44	475.27	435.82
Common Stock	544.63	544.63	544.63	544.63	544.63	544.63
Additional Paid-In Capital	3.65	3.65	3.65	25.44	25.44	25.44
Retained Earnings	824.08	891.19	771.66	460.46	323.74	115.14
Comprehensive Income & Other	-5.21	-13.42	5.33	-6.95	-4.97	-8.37
Total Common Equity	1,367	1,426	1,325	1,024	888.84	676.83
Shareholders' Equity	1,367	1,426	1,325	1,024	888.84	676.83
Total Liabilities & Equity	1,868	2,159	1,793	1,484	1,364	1,113
Total Debt	154.77	169.02	63.09	99.18	129.96	116.98
Net Cash (Debt)	498.73	792.78	753.58	580.16	779.64	610.94
Net Cash Growth	-22.30%	5.20%	29.89%	-25.59%	27.61%	21.63%
Net Cash Per Share	9.15	14.54	13.82	10.64	14.30	11.20
Filing Date Shares Outstanding	54.46	54.46	54.46	54.46	54.46	54.46
Total Common Shares Outstanding	54.46	54.46	54.46	54.46	54.46	54.46
Working Capital	600.84	621.51	579.57	453.62	671.02	550.09
Book Value Per Share	25.10	26.18	24.33	18.79	16.32	12.43
Tangible Book Value	1,363	1,421	1,321	1,020	883.66	668.09
Tangible Book Value Per Share	25.04	26.09	24.26	18.72	16.22	12.27
Land	64.9	-	-	-	-	-
Buildings	505.55	487.13	482.71	-	-	-
Machinery	342.5	293.4	82.42	62.95	98.43	82.2
Construction In Progress	8.1	17.79	-	331.26	86.92	9.75
Leasehold Improvements	45.89	44.01	44.79	44.4	44.82	5.4

Source: S&P Capital IQ. Standard template. Financial Sources.